William Lewis

CIK 1402051 · Chair and CEO · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$48.42M

Companies

4

Total Filings

96

Lifetime Open-Market Net

-$115.62M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INSM Chair and CEO 492,841 $97.85 $48.22M -$115.62M 91 2026-06-10
NAMSW Director 10,360 $18.80 $194.8K $0 3 2026-01-09
QURE Director $27.57 $0 1 2017-01-31
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted President, PFO and Treasurer 73,960 $0 1 2010-10-27

Recent Filings · Page 7 of 10

96 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-12-28 INSM Mixed -$1.36M EDGAR
2021-10-01 INSM Mixed -$2.32M EDGAR
2021-05-18 INSM Tax (F) −6,481 -$170.0K EDGAR
2021-05-14 INSM Grant (A) +28,344 $0 EDGAR
2021-03-18 INSM Mixed -$1.64M EDGAR
2021-01-08 INSM Grant (A) +22,039 $0 EDGAR
2021-01-06 INSM Tax (F) −7,218 -$240.7K EDGAR
2021-01-06 INSM Mixed $0 EDGAR
2020-12-23 INSM Mixed -$1.66M EDGAR
2020-11-06 INSM Mixed +28,639 -$5.79M EDGAR
Showing 6170 of 96
Page 7 of 10
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.